Product Description
Enfuvirtide is a 36 amino acid peptide corresponding to a region of gp41, the transmembrane subunit of HIV-1 envelope protein.Enfuvitide belongs to the therapeutic class of fusion inhibitors and acts by binding to gp41 and impeding the conformational chan
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Enfuvirtide is a fusion inhibitor peptide used in HIV treatment. Its molecular formula is <strong>C125H198N40O39S</strong> and CAS number is <strong>166822-72-2</strong>. Core synthesis involves solid-phase peptide synthesis.</p>
<h3>Application</h3>
<ul>
<li>HIV-1 infection management in combination therapy.</li>
<li>Antiretroviral regimens for multidrug-resistant strains.</li>
<li>Clinical trials evaluating novel viral entry inhibitors.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly injectable subcutaneously only. Requires refrigeration at 2-8°C. Avoid exposure to light. Contraindicated in hypersensitive patients.</p>